Tirzepatide, a novel medication, is generating considerable buzz within the scientific community. It works differently from common diabetes medications, targeting both receptors involved in blood regulation and appetite . Initial trials have demonstrated impressive efficacy in controlling blood levels in individuals with adult-onset diabetes and, i